Verified peer comparison
Opus Genetics vs Sonoma Pharmaceuticals Financial Comparison
Direct answer
Opus Genetics and Sonoma Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Opus Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Opus Genetics Revenue
- 14,196,000 USD
- Sonoma Pharmaceuticals Revenue
- 14,288,000 USD
- Opus Genetics Operating income
- -38,599,000 USD
- Sonoma Pharmaceuticals Operating income
- -3,710,000 USD